BDPT Stock Chart & Stats
$0.02
$0.02(22.86%)
At close: 4:00 PM EST
$0.02
$0.02(22.86%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.09
Previous CloseN/A
Volume23.97K
Average Volume (3M)142.01K
Market Cap
$14.63K
Enterprise Value$418.80K
Total Cash (Recent Filing)$73.61K
Total Debt (Recent Filing)$456.31K
Price to Earnings (P/E)―
Beta-1.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding12,008,659
10 Day Avg. Volume175,390
30 Day Avg. Volume142,011
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.10
Price to Sales (P/S)12.18
P/FCF Ratio-0.42
Enterprise Value/Market Cap28.63
Enterprise Value/Revenue17.60
Enterprise Value/Gross Profit26.41
Enterprise Value/Ebitda-0.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BDPT FAQ
What was BioAdaptives’s price range in the past 12 months?
BioAdaptives lowest stock price was <$0.01 and its highest was $0.09 in the past 12 months.
What is BioAdaptives’s market cap?
BioAdaptives’s market cap is $14.63K.
When is BioAdaptives’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioAdaptives’s earnings last quarter?
Currently, no data Available
Is BioAdaptives overvalued?
According to Wall Street analysts BioAdaptives’s price is currently Overvalued.
Does BioAdaptives pay dividends?
BioAdaptives does not currently pay dividends.
What is BioAdaptives’s EPS estimate?
BioAdaptives’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioAdaptives have?
BioAdaptives has 12,008,659 shares outstanding.
What happened to BioAdaptives’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioAdaptives?
Currently, no hedge funds are holding shares in BDPT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BioAdaptives
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. The company was incorporated in 2013 and is based in Las Vegas, Nevada.
Technical Analysis
Natural Alternatives International
―
Nature's Sunshine Products
―
USANA Health
―
FitLife Brands
―
Healthy Choice Wellness Corp. Class A
―